Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Artelo Biosciences Inc ARTL

Healthcare Biotechnology
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company’s product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated/ weight loss with... see more

Current News (NDAQ:ARTL)

Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate

GlobeNewswire December 23, 2025

Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical Models

GlobeNewswire December 3, 2025

Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results

GlobeNewswire November 12, 2025

Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer

GlobeNewswire November 4, 2025

Artelo Biosciences Names Veteran Life Sciences Executive Mark Spring, CPA, as Chief Financial Officer

GlobeNewswire October 27, 2025

Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit

GlobeNewswire October 15, 2025

Artelo Biosciences Announces Closing of $2.0 Million Public Offering

GlobeNewswire October 1, 2025

Artelo Biosciences Announces Pricing of $2.0 Million Public Offering

GlobeNewswire September 30, 2025

Artelo Biosciences Announces Proposed Underwritten Public Offering

GlobeNewswire September 29, 2025
View More News ››

Opinion & Analysis (NDAQ:ARTL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ARTL)

Buy buddy buy.

Otherwise it is FOMO time for you fellas out there today anyway,so good luck to all of us
coolfooldumbguy - July 9, 2025

Buy buddy buy.

You you guys out there will be missing out on this stock today and because it's FOMO time
coolfooldumbguy - July 7, 2025

Staying long and strong and

With this stock today and because of the strong technicals for it
coolfooldumbguy - June 30, 2025

Artelo Biosciences, Inc. (NASDAQ:ARTL): Developing Novel The

http://beyondspx.com/2024/08/01/artelo-biosciences-inc-nasdaqartl-developing-novel-therapeutics-targeting-the-endocannabinoid-system/
MikeTester - August 2, 2024

ARTL..... another bagholders nightmare?

Sheesh
Iseneschal - April 13, 2022

A TRUE HIDDEN GEM

Hard to believe there are no recent posts on this one. There is a youtube interview of the CEO in which he claims a pre-clinical study...
lemonn8buck - November 22, 2021
View more Bullboard ››

AE Fuels Corporation

AE Fuels Corporation

Cavalry Capital Corp. engages in the extraction and purification of minerals for batteries that power electrification and ...
View More »

Podcasts